Safety Alert for Product name: Estradiol Life II Technical Name: Estradiol Life II ANVISA Registration Number: 10158120172 Hazard Class: I Affected Model: Affected serial numbers: Lot: 1004403350, 1004343690, 1004490710, 1004661480, 1004666000.

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by bioMérieux Brasil S.A.; bioMérieux S.A.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    2172
  • Date
    2016-08-12
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    1- Sending a letter to the usual customers / distributors of the product (Annex to this Notice) with the guidelines necessary to use the product. 2- See the step-by-step action plan that will be developed to notify all customers until the manufacturer includes in the instructions for use the risk of cross-reaction of the Vidas Estradiol II kit with the drug Fulvestrant.
  • Reason
    Biomérieux sa france manufacturer of the product vidas estradiol ii, was contacted by the national agency for the safety of medicines and products for health of france - ansm; to verify the occurrence of cross-reaction of the kit in question, or other kits for dosing estradiol, with the product fulvestrant. this request came from the fact that ansm was informed of this occurrence with a siemens healthcare company product. based on ansm's report, biomérieux sa opened an internal investigation (pr965756) and a study was carried out with the vidas family of equipment (vidas, mini-vidas and vidas3) together with the vidas estradiol ii kit, the only test for estradiol by biomérieux sa the investigation concluded that fulvestrant is cross-reactive with the vidas test. the cross-reactivity study done according to the principles of the clsi guide ep7-a2 "interference test in clinical chemistry" guide approved second edition, demonstrated that the cross-reactivity percentage obtained for fulvestrant is a maximum of 0.32% for a drug concentration of 20,000pg / ml.
  • Action
    Field Action Code FSCA 3039 triggered under the responsibility of the company bioMérieux Brasil SA Company will inform the clients.

Manufacturer